NO20071967L - Imidazo-benzodiazepinderivater - Google Patents

Imidazo-benzodiazepinderivater

Info

Publication number
NO20071967L
NO20071967L NO20071967A NO20071967A NO20071967L NO 20071967 L NO20071967 L NO 20071967L NO 20071967 A NO20071967 A NO 20071967A NO 20071967 A NO20071967 A NO 20071967A NO 20071967 L NO20071967 L NO 20071967L
Authority
NO
Norway
Prior art keywords
imidazo
benzodiazepine
cognitive
triazolo
gaba
Prior art date
Application number
NO20071967A
Other languages
English (en)
Inventor
Andrew William Thomas
Henner Knust
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20071967L publication Critical patent/NO20071967L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse angår substituert imidazo[1,5-a][1,2,4]triazolo[1,5d][1,4]benzodiazepinderivater av den følgende formel: hvor R1, R2 og R3 er som definert i kravene og deres farmasøytisk akseptable syreaddisjonssalter. Det er funnet at denne klasse forbindelser viser høy affinitet og selektivitet for GABA A a5 reseptor bindingsseter, og de kan være anvendelige som kognitiv enhancere eller for behandling av kognitive lidelser, angst, schizofreni eller Alzheimer's sykdom.
NO20071967A 2004-10-20 2007-04-17 Imidazo-benzodiazepinderivater NO20071967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105169 2004-10-20
PCT/EP2005/010908 WO2006045430A1 (en) 2004-10-20 2005-10-11 Imidazo-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
NO20071967L true NO20071967L (no) 2007-05-14

Family

ID=36035782

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071967A NO20071967L (no) 2004-10-20 2007-04-17 Imidazo-benzodiazepinderivater

Country Status (18)

Country Link
US (1) US7514426B2 (no)
EP (1) EP1805184B1 (no)
JP (1) JP4783375B2 (no)
KR (1) KR100923399B1 (no)
CN (1) CN101044145B (no)
AR (1) AR051395A1 (no)
AU (1) AU2005299032B2 (no)
BR (1) BRPI0519991A2 (no)
CA (1) CA2584259C (no)
ES (1) ES2399439T3 (no)
IL (1) IL182585A0 (no)
MX (1) MX2007004639A (no)
NO (1) NO20071967L (no)
NZ (1) NZ554439A (no)
RU (1) RU2007112940A (no)
TW (1) TWI303247B (no)
WO (1) WO2006045430A1 (no)
ZA (1) ZA200703172B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063708A1 (en) * 2004-12-14 2006-06-22 F.Hoffmann-La Roche Ag Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
JP4885967B2 (ja) * 2005-10-11 2012-02-29 エフ．ホフマン−ラ ロシュ アーゲー イミダゾベンゾジアゼピン誘導体
FR2913886B1 (fr) 2007-03-22 2012-03-02 Guerbet Sa Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
EP2298296A1 (en) 2009-08-25 2011-03-23 CNRS Centre National De La Recherche Scientifique Composition and method for treating cognitive impairments in down syndrome subjects
US20130150351A1 (en) * 2010-06-03 2013-06-13 Stanley T. Carmichael Methods and compositions for treating a subject for central nervous system (cns) injury
CN103189062B (zh) * 2010-11-05 2016-03-23 霍夫曼-拉罗奇有限公司 活性药物化合物用于治疗中枢神经系统病症的用途
EP2457569A1 (en) 2010-11-05 2012-05-30 F. Hoffmann-La Roche AG Use of active pharmaceutical compounds for the treatment of central nervous system conditions
AU2011328993B2 (en) 2010-11-15 2017-03-02 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP4032889B1 (en) * 2013-12-20 2026-05-06 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
EP3310785B1 (en) * 2015-06-19 2024-11-20 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP7403050B2 (ja) * 2017-08-28 2023-12-22 ユニバーシティ オブ メリーランド ボルチモア 気分障害のための新規ガンマアミノ酪酸型受容体モジュレーター
AU2019288382B2 (en) 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
CS249146B2 (en) 1984-01-19 1987-03-12 Hoffmann La Roche Method of new imidazodiazepine's derivatives production
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
ZA881538B (en) * 1987-03-10 1988-09-12 F. Hoffmann-La Roche & Co. Aktiengesellschaft Imidazodiazepine derivatives
US4897392A (en) 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
TW201311B (no) * 1991-06-17 1993-03-01 Hoffmann La Roche
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives

Also Published As

Publication number Publication date
KR20070054731A (ko) 2007-05-29
AU2005299032A1 (en) 2006-05-04
BRPI0519991A2 (pt) 2009-04-07
MX2007004639A (es) 2007-06-08
CA2584259C (en) 2013-04-02
JP2008517011A (ja) 2008-05-22
TW200630372A (en) 2006-09-01
AU2005299032B2 (en) 2011-11-17
WO2006045430A1 (en) 2006-05-04
KR100923399B1 (ko) 2009-10-23
JP4783375B2 (ja) 2011-09-28
EP1805184A1 (en) 2007-07-11
AR051395A1 (es) 2007-01-10
RU2007112940A (ru) 2008-11-27
ZA200703172B (en) 2008-08-27
US7514426B2 (en) 2009-04-07
ES2399439T3 (es) 2013-04-01
NZ554439A (en) 2009-09-25
CA2584259A1 (en) 2006-05-04
TWI303247B (en) 2008-11-21
EP1805184B1 (en) 2013-01-09
IL182585A0 (en) 2007-07-24
CN101044145A (zh) 2007-09-26
US20060084642A1 (en) 2006-04-20
CN101044145B (zh) 2010-06-16

Similar Documents

Publication Publication Date Title
DE602007001893D1 (en) Aryl-4-ethinylisoxazolderivate
IL190867A0 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
IL189762A0 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
NO20072046L (no) Halogensubstituerte benzodiazepinderivater
WO2006119504A3 (en) Fused heterocyclic compounds, and compositions and uses thereof
WO2007011833A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
CR9389A (es) Compuestos de imidazopiridazina
MX2009014001A (es) Derivados de isoxazol-imidazol.
CY1110711T1 (el) Παραγωγα πυραζολο [3,4-d]αζεπινης ως ανταγωνιστες ισταμινης η3
CA2498291A1 (en) Diazabicyclic compounds useful in the treatment of cns and other disorders
WO2005090296A3 (en) N-substituted benzene sulfonamides
TW200734328A (en) Aryl-isoxazolo-4-yl-imidazo [1,5-a] pyridine derivatives
TW200630372A (en) Imidazo-benzodiazepine derivatives
WO2003070728A3 (en) Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
ATE360424T1 (de) 2,3,4,5-tetrahydrobenzo[fö]1,4öoxazepin-5- carbonsäureamid derivate als gamma-secretase inhibitoren zur behandlung von alzheimer
ATE402707T1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2009064836A3 (en) Kynurenine-aminotransferase inhibitors
ATE477255T1 (de) Imidazobenzdiazepinderivate
WO2007058862A3 (en) Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
TW200631953A (en) Tetracyclic imidazo-benzodiazepines
IL184439A0 (en) 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005007630A3 (en) Aryl fused azapolycyclic compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application